<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=FDU-PB-22</id>
	<title>FDU-PB-22 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=FDU-PB-22"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=FDU-PB-22&amp;action=history"/>
	<updated>2026-04-24T13:10:28Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=FDU-PB-22&amp;diff=5808213&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=FDU-PB-22&amp;diff=5808213&amp;oldid=prev"/>
		<updated>2024-05-22T17:06:33Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:FDU-PB-22_structure.png|thumb|FDU-PB-22_structure.png]] &amp;#039;&amp;#039;&amp;#039;FDU-PB-22&amp;#039;&amp;#039;&amp;#039; is a synthetic cannabinoid that has been used in scientific research and has been sold online as a designer drug. It is a potent agonist of the [[cannabinoid receptor]]s, which are part of the [[endocannabinoid system]].&lt;br /&gt;
&lt;br /&gt;
==Chemical Structure==&lt;br /&gt;
FDU-PB-22 is chemically classified as an indole-based synthetic cannabinoid. Its full chemical name is quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. The structure of FDU-PB-22 includes a fluoropentyl chain, which is a common feature in many synthetic cannabinoids, contributing to its high potency.&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
FDU-PB-22 acts as a potent agonist at the [[CB1 receptor|CB1]] and [[CB2 receptor|CB2]] cannabinoid receptors. These receptors are part of the [[endocannabinoid system]], which plays a role in regulating various physiological processes including pain sensation, mood, and appetite. The binding affinity of FDU-PB-22 to these receptors is high, which accounts for its strong psychoactive effects.&lt;br /&gt;
&lt;br /&gt;
==Legal Status==&lt;br /&gt;
The legal status of FDU-PB-22 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. For example, in the [[United States]], it is listed as a Schedule I controlled substance under the [[Controlled Substances Act]].&lt;br /&gt;
&lt;br /&gt;
==Health Effects and Risks==&lt;br /&gt;
The use of FDU-PB-22 has been associated with a range of adverse health effects. These can include [[tachycardia]], [[hypertension]], [[nausea]], [[vomiting]], and [[anxiety]]. Due to its high potency, there is a significant risk of overdose, which can lead to severe health complications or death.&lt;br /&gt;
&lt;br /&gt;
==Research and Applications==&lt;br /&gt;
FDU-PB-22 has been used in scientific research to study the [[endocannabinoid system]] and the effects of synthetic cannabinoids. However, due to its potential for abuse and adverse health effects, its use is highly regulated and often restricted to laboratory settings.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[Synthetic cannabinoids]]&lt;br /&gt;
* [[Cannabinoid receptor]]&lt;br /&gt;
* [[Endocannabinoid system]]&lt;br /&gt;
* [[Designer drug]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
{{Commons category|FDU-PB-22}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Synthetic cannabinoids]]&lt;br /&gt;
[[Category:Designer drugs]]&lt;br /&gt;
[[Category:Controlled substances]]&lt;br /&gt;
[[Category:Research chemicals]]&lt;br /&gt;
&lt;br /&gt;
{{Drug-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>